Evli Likvidi vs SEB Bioteknikfond D

Evli Likvidi vs SEB Bioteknikfond D

1. Evli Likvidi

  • Security

    Evli Likvidi B

  • Fee

    0.31%

  • ISIN

    FI0008804463

  • Holdings

    9

2. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

Fund Holdings

We have information about 13 holdings in Evli Likvidi, where the largest holding is Teollisuuden Voima (1.84), followed by Nordea (1.7) and Akelius (1.39). In comparison with SEB Bioteknikfond D, we have 24 holdings where Gilead Sciences is the largest holding (10.04), followed by Vertex (8.8) and Amgen (8.54).

All Holdings

Here we compare the holdings in Evli Likvidi and SEB Bioteknikfond D.

Evli Likvidi SEB Bioteknikfond D
1. Teollisuuden Voima Oyj
Finland
1.84 %
1. Gilead Sciences Inc
USA
10.04 %
2. Nordea Bank Abp
Finland
1.7 %
2. Vertex Pharmaceuticals Inc
8.8 %
3. Akelius Residential D
Sweden
1.39 %
3. Amgen Inc
8.54 %
4. SSAB B
Sweden
1.2 %
4. Regeneron Pharmaceuticals Inc
5.09 %
5. Stora Enso Oyj R
Finland
1.15 %
5. Alnylam Pharmaceuticals Inc
5.07 %
6. Luminor Bank AS
Estonia
1.14 %
6. AstraZeneca ADR
Sweden UK
4.49 %
7. Skanska B
Sweden
1.06 %
7. Verona Pharma ADR
3.46 %
8. Kojamo Oyj
Finland
1.06 %
8. Argenx ADR
2.72 %
9. Akelius Residential Property Finance BV
1.04 %
9. Illumina Inc
2.72 %
- 10. BioNTech SE
2.41 %
- 11. Madrigal Pharmaceuticals Inc
1.88 %
- 12. BoneSupport AB
Sweden
1.82 %
- 13. BioMarin Pharmaceutical Inc
1.7 %
- 14. Krystal Biotech Inc
1.48 %
- 15. NewAmsterdam Pharma NV
1.46 %
- 16. BridgeBio Pharma Inc
1.45 %
- 17. Cytokinetics Inc
1.4 %
- 18. Ionis Pharmaceuticals Inc
1.37 %
- 19. Xenon Pharmaceuticals
1.37 %
- 20. Insmed Inc
1.32 %
- 21. Onward Medical NV
1.31 %
- 22. Janux Therapeutics Inc
1.3 %
- 23. Structure Therapeutics ADR
1.24 %
- 24. Kymera Therapeutics Inc
1.09 %

The list of fund holdings was last updated on June 5, 2025.